Successful use of fenfluramine as an add-on treatment for Dravet syndrome

Epilepsia

Volumn 53, Issue 7, 2012, Pages 1131-1139

  Ceulemans, Berten ^a,b   Boel, Marc ^b,c   Leyssens, Katrien ^a   Van Rossem, Carolin ^a   Neels, Pieter ^d   Jorens, Philippe G ^a   Lagae, Lieven ^b,c  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b Epilepsy Center for Children and Youth   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d Federal Agency for Medical and Health Products   (Belgium)

Author keywords

Dravet syndrome; Fenfluramine; Orphan drugs; SCN1A; Severe myoclonic epilepsy in infancy

Indexed keywords

CLOBAZAM; ETHOSUXIMIDE; ETIRACETAM; FENFLURAMINE; LAMOTRIGINE; LOFLAZEPATE; LORAZEPAM; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG SAFETY; FEMALE; HEART VALVE STENOSIS; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETREATMENT; SCHOOL CHILD; SEVERE MYOCLONIC EPILEPSY IN INFANCY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 85027936435     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2012.03495.x     Document Type: Article

References (48)

1. Aicardi J, Gastaut H,. (1985) Treatment of self-induced photosensitive epilepsy with fenfluramine. N Engl J Med 313: 1419. (Pubitemid 16211853)
2. Aicardi J, Gastaut H, Mises J,. (1988) Syncopal attacks compulsively self-induced by Valsalva's maneuver associated with typical absence seizures. A case report. Arch Neurol 45: 923-925.
3. Akiyama M, Kobayashi K, Yoshinaga H, Ohtsuka Y,. (2010) A long-term follow-up study of Dravet syndrome up to adulthood. Epilepsia 51: 1043-1052.
4. Andrade DM, Hamani C, Lozano AM, Wennberg RA,. (2010) Dravet syndrome and deep brain stimulation: seizure control after 10 years of treatment. Epilepsia 51: 1314-1316.
5. Belohlavkova S, Simak J, Kokesova A, Hnilickova O, Hampl V,. (2001) Fenfluramine-induced pulmonary vasoconstriction: role of serotonin receptors and potassium channels. J Appl Physiol 91: 755-761. (Pubitemid 32681108)
6. Boel M, Casaer P,. (1996) Add-on therapy of fenfluramine in intractable self-induced epilepsy. Neuropediatrics 27: 171-173. (Pubitemid 26319248)
7. Caraballo RH,. (2011) Nonpharmacologic treatments of Dravet syndrome: focus on the ketogenic diet. Epilepsia 52 (Suppl. 2): 79-82.
8. Casaer P, Boel M,. (2002) Fenfluramine as a potential antiepileptic drug. Epilepsia 43: 205-206.
9. Ceulemans B,. (2011) Overall management of patients with Dravet syndrome. Dev Med Child Neurol 53 (Suppl. 2): 19-23.
10. Ceulemans B, Boel M, Claes L, Dom L, Willekens H, Thiry P, Lagae L,. (2004) Severe myoclonic epilepsy in infancy: toward an optimal treatment. J Child Neurol 19: 516-521. (Pubitemid 39481251)
11. Chiron C, Dulac O,. (2011) The pharmacologic treatment of Dravet syndrome. Epilepsia 52 (Suppl. 2): 72-75.
12. Chiron C, Marchand MC, Tran A, Rey E, d'Athis P, Vincent J, Dulac O, Pons G,. (2000) Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet 356: 1638-1642.
13. Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P,. (2001) De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 68: 1327-1332. (Pubitemid 32510608)
14. Clemens B,. (1988) Dopamine agonist treatment of self-induced pattern-sensitive epilepsy. A case report. Epilepsy Res 2: 340-343.
15. Commission. (1981) Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 22: 489-501.
16. Connolly JM, Bakay MA, Fulmer JT, Gorman RC, Gorman JH 3rd, Oyama MA, Levy RJ,. (2009) Fenfluramine disrupts the mitral valve interstitial cell response to serotonin. Am J Pathol 175: 988-997.
17. Coppola G, Capovilla G, Montagnini A, Romeo A, Spano M, Tortorella G, Veggiotti P, Viri M, Pascotto A,. (2002) Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial. Epilepsy Res 49: 45-48. (Pubitemid 34304205)
18. Dahl CF, Allen MR, Urie PM, Hopkins PN,. (2008) Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals. BMC Med 6: 34.
19. Dravet C,. (1978) Les épilepsies graves de l'enfant. Vie Méd 8: 543-548.
20. Dravet C,. (2011) The core Dravet syndrome phenotype. Epilepsia 52 (Suppl. 2): 3-9.
21. Dravet C, Bureau M, Oguni H, Fukuyama Y, Cokar O,. (2005) Severe myoclonic epilepsy in infancy (Dravet syndrome). In, Roger CW, Bureau M, Dravet C, Genton P, Tassinari CA, Wolf F, (Eds) Epileptic syndromes in infancy, childhood and adolescence. John Libbey Eurotext Ltd, Paris, pp. 89-103.
22. Dravet C, Bureau M, Dalla Bernardina B, Guerrini R,. (2011) Severe myoclonic epilepsy in infancy (Dravet syndrome) 30 years later. Epilepsia 52 (Suppl. 2): 1-2.
23. Dura-Trave T, Yoldi-Petri ME, Gallinas-Victoriano F,. (2007) Epilepsy in children in Navarre, Spain: epileptic seizure types and epileptic syndromes. J Child Neurol 22: 823-828. (Pubitemid 47261233)
24. Fujiwara T, Watanabe M, Takahashi Y, Higashi T, Yagi K, Seino M,. (1992) Long-term course of childhood epilepsy with intractable grand mal seizures. Jpn J Psychiatry Neurol 46: 297-302.
25. Gastaut H, Zifkin B, Rufo M,. (1987) Compulsive respiratory stereotypies in children with autistic features: polygraphic recording and treatment with fenfluramine. J Autism Dev Disord 17: 391-406. (Pubitemid 18029060)
26. Genton P, Velizarova R, Dravet C,. (2011) Dravet syndrome: the long-term outcome. Epilepsia 52 (Suppl. 2): 44-49.
27. Gentsch K, Heinemann U, Schmitz B, Behr J,. (2000) Fenfluramine blocks low-Mg2 + -induced epileptiform activity in rat entorhinal cortex. Epilepsia 41: 925-928. (Pubitemid 30640853)
28. Harkin LA, McMahon JM, Iona X, Dibbens L, Pelekanos JT, Zuberi SM, Sadleir LG, Andermann E, Gill D, Farrell K, Connolly M, Stanley T, Harbord M, Andermann F, Wang J, Batish SD, Jones JG, Seltzer WK, Gardner A, Sutherland G, Berkovic SF, Mulley JC, Scheffer IE,. (2007) The spectrum of SCN1A-related infantile epileptic encephalopathies. Brain 130: 843-852. (Pubitemid 46410748)
29. Hurst DL,. (1990) Epidemiology of severe myoclonic epilepsy of infancy. Epilepsia 31: 397-400. (Pubitemid 20226666)
30. Iannetti P, Parisi P, Spalice A, Ruggieri M, Zara F,. (2009) Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy. Epilepsy Res 85: 89-95.
31. Inoue Y, Ohtsuka Y, Oguni H, Tohyama J, Baba H, Fukushima K, Ohtani H, Takahashi Y, Ikeda S,. (2009) Stiripentol open study in Japanese patients with Dravet syndrome. Epilepsia 50: 2362-2368.
32. Jansen FE, Sadleir LG, Harkin LA, Vadlamudi L, McMahon JM, Mulley JC, Scheffer IE, Berkovic SF,. (2006) Severe myoclonic epilepsy of infancy (Dravet syndrome): recognition and diagnosis in adults. Neurology 67: 2224-2226. (Pubitemid 46035482)
33. Jobe PC, Browning RA,. (2005) The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant. Epilepsy Behav 7: 602-619. (Pubitemid 43013007)
34. Kroll-Seger J, Portilla P, Dulac O, Chiron C,. (2006) Topiramate in the treatment of highly refractory patients with Dravet syndrome. Neuropediatrics 37: 325-329. (Pubitemid 46480526)
35. Marini C, Scheffer IE, Nabbout R, Mei D, Cox K, Dibbens LM, McMahon JM, Iona X, Carpintero RS, Elia M, Cilio MR, Specchio N, Giordano L, Striano P, Gennaro E, Cross JH, Kivity S, Neufeld MY, Afawi Z, Andermann E, Keene D, Dulac O, Zara F, Berkovic SF, Guerrini R, Mulley JC,. (2009) SCN1A duplications and deletions detected in Dravet syndrome: implications for molecular diagnosis. Epilepsia 50: 1670-1678.
36. Marini C, Mei D, Parmeggiani L, Norci V, Calado E, Ferrari A, Moreira A, Pisano T, Specchio N, Vigevano F, Battaglia D, Guerrini R,. (2010) Protocadherin 19 mutations in girls with infantile-onset epilepsy. Neurology 75: 646-653.
37. Marini C, Scheffer IE, Nabbout R, Suls A, De Jonghe P, Zara F, Guerrini R,. (2011) The genetics of Dravet syndrome. Epilepsia 52 (Suppl. 2): 24-29.
38. McCann UD, Seiden LS, Rubin LJ, Ricaurte GA,. (1997) Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence. JAMA 278: 666-672. (Pubitemid 27373842)
39. Nieto-Barrera M, Candau R, Nieto-Jimenez M, Correa A, del Portal LR,. (2000) Topiramate in the treatment of severe myoclonic epilepsy in infancy. Seizure 9: 590-594. (Pubitemid 32094376)
40. Nolan K, Camfield CS, Camfield PR,. (2008) Coping with a child with Dravet syndrome: insights from families. J Child Neurol 23: 690-694. (Pubitemid 351715915)
41. Oguni H, Hayashi K, Awaya Y, Fukuyama Y, Osawa M,. (2001) Severe myoclonic epilepsy in infants-a review based on the Tokyo Women's Medical University series of 84 cases. Brain Dev 23: 736-748. (Pubitemid 32999159)
42. Riva D, Vago C, Pantaleoni C, Bulgheroni S, Mantegazza M, Franceschetti S,. (2009) Progressive neurocognitive decline in two children with Dravet syndrome, de novo SCN1A truncations and different epileptic phenotypes. Am J Med Genet A 149A: 2339-2345.
43. Spencer DC, Hwang J, Morrell MJ,. (2000) Fenfluramine-phentermine (Fen-Phen) and seizures: evidence for an association. Epilepsy Behav 1: 448-452.
44. Striano P, Coppola A, Pezzella M, Ciampa C, Specchio N, Ragona F, Mancardi MM, Gennaro E, Beccaria F, Capovilla G, Rasmini P, Besana D, Coppola GG, Elia M, Granata T, Vecchi M, Vigevano F, Viri M, Gaggero R, Striano S, Zara F,. (2007) An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy. Neurology 69: 250-254. (Pubitemid 47205686)
45. Suls A, Claeys KG, Goossens D, Harding B, Van Luijk R, Scheers S, Deprez L, Audenaert D, Van Dyck T, Beeckmans S, Smouts I, Ceulemans B, Lagae L, Buyse G, Barisic N, Misson JP, Wauters J, Del-Favero J, De Jonghe P, Claes LR,. (2006) Microdeletions involving the SCN1A gene may be common in SCN1A-mutation- negative SMEI patients. Hum Mutat 27: 914-920. (Pubitemid 44336941)
46. Thanh TN, Chiron C, Dellatolas G, Rey E, Pons G, Vincent J, Dulac O,. (2002) [Long-term efficacy and tolerance of stiripentaol in severe myoclonic epilepsy of infancy (Dravet's syndrome)]. Arch Pediatr 9: 1120-1127. (Pubitemid 35429290)
47. Yakoub M, Dulac O, Jambaque I, Chiron C, Plouin P,. (1992) Early diagnosis of severe myoclonic epilepsy in infancy. Brain Dev 14: 299-303.
48. Zamponi N, Passamonti C, Cappanera S, Petrelli C,. (2011) Clinical course of young patients with Dravet syndrome after vagal nerve stimulation. Eur J Paediatr Neurol 15: 8-14.